Products

What will AGI do for Aurotioprol?

This classification denotes an antirheumatic agent with the molecular formula C3H6O4S2.Au.Na, , a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G7097J63E9, chemically known as 1-propanesulfonic acid, 2-hydroxy-3-mercapto-, gold complex but more generally known as aurotioprol, which bears US NIH Compound Identifier 44144564. European Medicines Agency schedules aurotioprol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12966MIG. As of Q4 2014, AUROTIOPROL remains US FDA's Preferred Term for this commodity. SMILES: C(C(CS(=O)(=O)O)O)S.[Na+].[Au+].

How AGI delivers it

Four ways AGI delivers for Aurotioprol

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aurotioprol, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aurotioprol, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aurotioprol connects

measured by

  • Assay Puritymodel
  • Gold Contentmodel
  • Residual Solventmodel